Cite
MLA Citation
Philip D. Home et al.. “Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison.” Diabetes, obesity & metabolism, vol. 23, no. 12, 2021, pp. 2660–2669. http://access.bl.uk/ark:/81055/vdc_100145639870.0x000020